EBS - Emergent Biosolutions' (EBS) CEO Bob Kramer on Q2 2021 Results - Earnings Call Transcript

Emergent Biosolutions, Inc. (EBS) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Bob Burrows – Investor Relations Bob Kramer – President and Chief Executive Officer Rich Lindahl – Chief Financial Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Jessica Fye – JPMorgan Jacob Hughes – Wells Fargo Securities Keay Nakae – Chardan Lisa Springer – Singular Research Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Emergent BioSolutions Second Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Bob Burrows, Investor Relations Officer for the company. Please proceed. Bob Burrows Thank you, Michelle and good afternoon everyone. Thank you for joining us today as we discuss the operational and financial results for the second quarter of 2021. As is customary, today’s call is open to all

For further details see:

Emergent Biosolutions' (EBS) CEO Bob Kramer on Q2 2021 Results - Earnings Call Transcript